⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Saro AvakianM.D.

Family Practice · Glendale, CA 91204

NPI: 1073651550

Share:

28

🟡 Moderate

Risk Flags

High cost outlier (population + peer)Elevated antipsychotic prescribing (65+)Opioid + benzodiazepine co-prescriberExtreme fills per patient

Risk indicators are statistical patterns, not allegations. Learn more

30,491

Total Claims

$3.3M

Drug Cost

583

Beneficiaries

$5,702

Cost/Patient

Risk Score Breakdown 28/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid + benzodiazepine combo+8
Cost per patient outlier+6
Elderly antipsychotic prescribing+5
High fills per patient+5

Score components are additive. Read full methodology

Peer Comparison vs. 106,889 Family Practice providers

-78%

Opioid rate vs peers

0.6% vs 2.6% avg

+434%

Cost per patient vs peers

$5,702 vs $1,068 avg

+98%

Brand preference vs peers

17.8% vs 9.0% avg

⚠️ Opioid + Benzodiazepine Co-Prescriber

This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.

🔎 Data Overview

⚠️

This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

0.6%

Opioid Rate

172

Opioid Claims

$1,373

Opioid Cost

Long-Acting Rate

Brand vs Generic

82% generic

Brand: 5,389 claims · $2.7M

Generic: 24,860 claims · $619K

Top Prescribed Drugs

Drug (Generic)ClaimsCost
Lipase/Protease/Amylase252$349K
Linaclotide470$279K
Icosapent Ethyl782$242K
Empagliflozin280$210K
Apixaban208$121K
Dulaglutide113$117K
Sitagliptin Phosphate166$93K
Linagliptin166$90K
Mirabegron172$90K
Semaglutide81$85K
Denosumab45$77K
Vortioxetine Hydrobromide106$76K
Dapagliflozin Propanediol109$71K
Plecanatide75$59K
Semaglutide58$58K

Prescribing Profile

202

Unique Drugs

$564K

IRA Negotiated Drugs

$260K

GLP-1 Drugs

28.0

Anomaly Score

Patient Profile

78

Avg Age

60%

Female

1.56

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data